Agilvax Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Agilvax Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11163
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥101,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Agilvax Inc (Agilvax) is a drug company that discovers and develops vaccines against infectious diseases and immunotherapies to treat cancer. The company develops products based on a proprietary virus-like particle platform technology. It develops immunotherapies to treat breast cancer, lung cancer and melanoma, among others. Agilvax develops AX03, a lead vaccine candidate, for human papilloma virus prevention. The company also develops vaccines against infectious diseases such as respiratory syncytial virus, malaria and dengue, among others. It evaluates its lead immunotherapy candidates through in vitro and in vivo tests for clinical efficacy. The company also partners with industry, academia, and government institutions for developing immunotherapies and vaccines. Agilvax is headquartered in Albuquerque, New Mexico, the US.

Agilvax Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Agilvax Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Agilvax Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Agilvax Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Agilvax Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Agilvax Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Agilvax Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Agilvax Raises Funds through Series A1 Venture Financing 10
Agilvax Raises USD0.5 Million in Venture Financing 11
Agilvax Raises USD2 Million in Series A Venture Financing 12
AgilVax Raises USD1 Million in Venture Financing 13
Agilvax, Developer Of Vaccines, To Raise US$2 Million In Venture Financing 14
Partnerships 15
Agilvax Enters into Co-Development Agreement with Integrated BioTherapeutics 15
Agilvax Enters into Co-Development Agreement with Sandia National Labs 16
Agilvax Enters into Development Agreement with Humabs Biomed 17
Agilvax Inc – Key Competitors 18
Agilvax Inc – Key Employees 19
Agilvax Inc – Locations And Subsidiaries 20
Head Office 20
Recent Developments 21
Product News 21
05/01/2018: Agilvax Establishes Operations at JLABS @ TMC in Houston 21
03/31/2017: Agilvax to Showcase Data During AACR 2017 Annual Meeting in Washington, DC 22
Clinical Trials 23
Dec 05, 2017: New Scientific Publication Supports Agilvax’s Novel Immunotherapy Development for Metastatic Breast Cancer 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
Agilvax Inc, Pharmaceuticals & Healthcare, Key Facts 2
Agilvax Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Agilvax Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Agilvax Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Agilvax Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Agilvax Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Agilvax Raises Funds through Series A1 Venture Financing 10
Agilvax Raises USD0.5 Million in Venture Financing 11
Agilvax Raises USD2 Million in Series A Venture Financing 12
AgilVax Raises USD1 Million in Venture Financing 13
Agilvax, Developer Of Vaccines, To Raise US$2 Million In Venture Financing 14
Agilvax Enters into Co-Development Agreement with Integrated BioTherapeutics 15
Agilvax Enters into Co-Development Agreement with Sandia National Labs 16
Agilvax Enters into Development Agreement with Humabs Biomed 17
Agilvax Inc, Key Competitors 18
Agilvax Inc, Key Employees 19

List of Figures
Agilvax Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Agilvax Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Agilvax Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Agilvax Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Agilvax Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Agilvax Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Agilvax Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Agilvax Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Agilvax Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Continental Resources Inc Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Continental Resources Inc Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Continental Resources Inc (Continental Resources) is an oil and gas company involved in the distribution of fuel and related products and services. The company offerings include supply fulf …
  • Cincinnati Financial Corp:企業の戦略・SWOT・財務情報
    Cincinnati Financial Corp - Strategy, SWOT and Corporate Finance Report Summary Cincinnati Financial Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Boehringer Ingelheim GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Boehringer Ingelheim GmbH (Boehringer), a subsidiary of CH Boehringer Sohn AG & Co KG is a pharmaceutical company that conducts research, development, manufacture and sale of pharmaceuticals. It offers a wide range of products including human diseases, animal health care products and biophar …
  • MediPal Holdings Corp:企業の戦略・SWOT・財務情報
    MediPal Holdings Corp - Strategy, SWOT and Corporate Finance Report Summary MediPal Holdings Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Electricity Supply Board:企業の戦略・SWOT・財務分析
    Electricity Supply Board - Strategy, SWOT and Corporate Finance Report Summary Electricity Supply Board - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Korea Development Bank:企業の戦略・SWOT・財務情報
    Korea Development Bank - Strategy, SWOT and Corporate Finance Report Summary Korea Development Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Accent Group Ltd (AX1):企業の財務・戦略的SWOT分析
    Accent Group Ltd (AX1) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Steris Corp:医療機器:M&Aディール及び事業提携情報
    Summary Steris Corp (Steris), formerly Innovative Medical Technologies, a subsidiary of Steris Plc, is a medical device company which offers infection prevention and other procedural products and services. The company offers surgical equipment and image management devices, sterile processing equipme …
  • Premier Foods plc (PFD):企業の財務・戦略的SWOT分析
    Premier Foods plc (PFD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • BW Offshore Ltd (BWO):企業の財務・戦略的SWOT分析
    BW Offshore Ltd (BWO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • ImCheck Therapeutics SAS:製薬・医療:M&Aディール及び事業提携情報
    Summary ImCheck Therapeutics SAS (ImCheck Therapeutics) is an independent biotechnology company that develops drugs for cancer and auto-immune disorders. The company is developing two first-in-class immunomodulator antibodies that are effective against adaptive and innate immunity to treat cancer an …
  • Sojitz Corp (2768):石油・ガス:M&Aディール及び事業提携情報
    Summary Sojitz Corp (Sojitz) is a diversified general trading group. The group through its subsidiaries and affiliates holds interest in machinery; energy and metals; chemicals and functional materials; and consumer lifestyle businesses. It distributes automobiles and aircraft; develops power projec …
  • Cullen Resources Ltd:企業の財務・戦略的SWOT分析
    Summary Cullen Resources Ltd (Cullen) is a mining company that offers mineral exploration solutions. The company carries out the business of acquisition, exploration, and development of copper, iron, gold, and nickel properties. Its projects include West Pilbara Iron Ore project, Wyloo project, West …
  • Larix AS:製薬・医療:M&Aディール及び事業提携情報
    Summary Larix A/S (Larix) is a contract research organization that offers services related to clinical trials assistance. The organization provides services such as statistics, data management, clinical research, pharmacovigilance and data monitoring among others. It offers services across all phase …
  • Empresa Electricidad del Peru SA (ELECPBC1):企業の財務・戦略的SWOT分析
    Empresa Electricidad del Peru SA (ELECPBC1) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key streng …
  • Condor Petroleum Inc (CPI):企業の財務・戦略的SWOT分析
    Condor Petroleum Inc (CPI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Dragon Oil Plc:石油・ガス:M&Aディール及び事業提携情報
    Summary Dragon Oil Plc (Dragon Oil), a subsidiary of Emirates National Oil Company Ltd, is an independent oil and gas company that carries out acquisition, exploration, and development of hydrocarbon resources. It focuses on properties in offshore Turkmenistan and exploration assets in Iraq, Algeria …
  • ActiveCare Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary ActiveCare Inc (ActiveCare) is a medical equipment company that monitors health analytics. The company provides monitoring component to traditional disease management and wellness solutions. It offers solutions such as diabetes supplies, online web-based administrative tools, browser and iPh …
  • Hydro One Ltd (H):電力:M&Aディール及び事業提携情報
    Summary Hydro One Ltd (Hydro One) is a utility holding company that conducts electricity transmission and distribution in Ontario through its subsidiaries. It also undertakes telecommunications business and certain corporate activities. The company serves residential, commercial and industrial custo …
  • Croatia Airlines d.d.:企業の戦略・SWOT・財務情報
    Croatia Airlines d.d. - Strategy, SWOT and Corporate Finance Report Summary Croatia Airlines d.d. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆